Back
Perspective Therapeutics Stock Predictions
Sponsored
CATX
Sponsored
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
30
CATX
Perspective Therapeutics
Last Price:
12.34
Seasonality Move:
26.28%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholePerspective Therapeutics Stock Forecast
- Over the next 52 weeks, Perspective Therapeutics has on average historically risen by 20.4% based on the past 20 years of stock performance.
- Perspective Therapeutics has risen higher in 6 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%
-
Is Perspective Therapeutics Stock Undervalued?
The current Perspective Therapeutics [CATX] share price is $12.34. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal. - CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Perspective Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Perspective Therapeutics has on average historically risen by 20.4% based on the past 20 years of stock performance.
Perspective Therapeutics Stock Rating
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics overpriced?
- Perspective Therapeutics has risen higher in 6 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%
Perspective Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
perspectivetherapeutics.com
52-Week Data
52-Week High:
19.05
52-Week Low:
2.20
Prediction Charts
Market Cap:
832.06M
Price in USD:
12.34
Volume:
425.87K
Beta:
1.34
Technical Analysis
SMA50:
13.38
SMA100:
12.78
SMA200:
12.62
52-Wk Change:
351.35%
Stock Predictions
-
Is Perspective Therapeutics stock public?
Yes, Perspective Therapeutics is a publicly traded company. -
What is the Perspective Therapeutics stock quote today?
The Perspective Therapeutics stock price is 12.34 USD today. -
How to buy Perspective Therapeutics stock online?
You can buy Perspective Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-16 | 12.57 | 13.00 | 13.15 | 12.44 |
Oct-18 | 12.30 | 12.65 | 12.72 | 11.93 |
Oct-21 | 12.57 | 12.70 | 12.84 | 12.40 |
Oct-22 | 12.69 | 12.39 | 12.69 | 12.19 |
Oct-23 | 12.29 | 11.69 | 12.40 | 11.65 |
Oct-24 | 12.28 | 11.89 | 12.31 | 11.80 |
Oct-25 | 11.93 | 11.53 | 11.96 | 11.50 |
Oct-28 | 11.77 | 11.91 | 12.46 | 11.55 |
Oct-29 | 11.76 | 11.87 | 12.09 | 11.69 |
Oct-30 | 11.81 | 11.47 | 11.94 | 11.43 |
Oct-31 | 11.40 | 11.81 | 11.95 | 11.40 |
Nov-1 | 11.97 | 12.09 | 12.21 | 11.64 |
Nov-4 | 12.09 | 12.19 | 12.90 | 11.79 |
Nov-5 | 12.15 | 12.34 | 12.39 | 11.95 |
Perspective Therapeutics Earnings
Perspective Therapeutics Earnings Report: Per Share Perspective Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Perspective Therapeutics Forecast Revenue Growth
Perspective Therapeutics Stock Analysis: Historical quarterly revenues per share for Perspective Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.17 per share.
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.